zohman

5 POSTS 0 COMMENTS

Rivaroxaban recommended by NICE for peripheral and coronary artery disease patients

xarelto rivaroxaban
The National Institute for Health and Care Excellence (NICE) in the UK has published a positive draf...

Alvimedica announces CE mark for Cre8 Evo 2mm

Alvimedica has announced the company has received the CE mark for the Cre8 Evo 2mm, a polymer-free A...

Society for Cardiovascular Angiography and Interventions supports continued use of paclitaxel devices

SCAI
Experts from the Society for Cardiovascular Angiography and Interventions (SCAI) have reviewed the r...

Nearly 25% of chronic ischaemic heart disease patients dead or hospitalised in six months

¬†   Nearly a quarter of patients¬†with chronic ischaemic cardiovascular disease are dead o...

Analysis of LAA closure devices reveals post-approval spike in safety events

  A retrospective study conducting a safety assessment and comparison between two percut...